Zhaoke Ophthalmology (6622.HK) Earnings Analysis

Zhaoke Ophthalmology (6622.HK) next reports earnings on 2026-08-26, consensus EPS -0.28181 HKD. It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -5.98.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6622.HK next report earnings?

Next earnings date2026-08-26
Consensus EPS estimate-0.28181 HKD
Revenue estimate0.00B

6622.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-06-30-0.23363 HKDn/an/an/a
2025-03-24-0.31495 HKD-0.41509 HKD+24.1%Beat
2024-08-29-0.14905 HKD-0.36531 HKD+59.2%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

6622.HK valuation and analyst view

Trailing P/E-5.98
Trailing EPS-0.37852 HKD
Price / book0.79
Dividend yield0.00%
Market cap1.44B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Zhaoke Ophthalmology (6622.HK)'s next earnings date?

Zhaoke Ophthalmology is next scheduled to report on 2026-08-26, with a consensus EPS estimate of -0.28181 HKD and revenue estimate of 0.00B.

Did 6622.HK beat earnings last quarter?

Consensus estimate data was not available for 6622.HK's 2025-06-30 report.

What is 6622.HK's earnings track record?

Over the last 2 reported quarters with consensus data, 6622.HK beat estimates 2 times (100%).

What is 6622.HK's current P/E ratio and EPS?

6622.HK trades at a trailing P/E of -5.98 on trailing EPS of -0.37852284919748624 HKD.

What do analysts rate 6622.HK?

6622.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.